Skip to main content

$0.062 0.002 (3.33%)

High

$0.06

Low

$0.06

Trades

18

Turnover

$32,113

Volume

526,676
30 June 2023 at 3:59pm
Register to track DXB and receive email alerts.

DSMB Recommends Continuation of Ph3 COVID-19 Study in Europe

StockBot

416,823 posts

DXB released this announcement to the ASX on 16 December 2021, 12:12. The announcement is marked as price sensitive, and is 5 page(s) in length and 336.58kb in size.

You can view all announcements from DXB and see how they appear on a price chart on the announcements page.

At the date of this announcement, DXB was 0.021% short sold according to ASIC data. It was ranked the 590th most shorted stock on the ASX. It is now ranked as the 444th most shorted stock on the ASX with 0.114% of total shares short sold as of the latest reported data (26 May 2026).

Other Recent Announcements from DXB
Application for quotation of securities - DXB 29 June 2023, 9:01
Application for quotation of securities - DXB 29 June 2023, 9:00
Application for quotation of securities - DXB 29 June 2023, 8:59
DSMB Recommends Continuation of Ph3 COVID-19 Study in Europe 16 December 2021, 12:12
Pause in Trading 16 December 2021, 10:02
Notification regarding unquoted securities - DXB 6 December 2021, 15:05
Investor Presentation 23 November 2021, 8:55
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track DXB and receive email alerts.